Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 14, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing organization (CDMO), has delivered its comprehensive review of the injectables market – both sterile and small molecule – for the next 5 years during its ...
read more
Tuesday, October 20, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of two respected industry veterans to its business ...
read more
Tuesday, October 20, 2015
The contract development and manufacturing organisation, Recipharm AB has entered into an agreement whereby it will acquire a majority stake in Nitin Lifesciences Limited, an Indian sterile injectables CMO, currently owned by the Sobti family.
read more
Tuesday, October 20, 2015
Intertek has formally launched the expanded GLP Bioanalytical Centre of Excellence in San Diego, California, USA to deliver world-class bioanalysis
read more
Tuesday, October 20, 2015
Quintiles announced that Kevin Gordon, currently serving as Executive Vice President, Operations and Chief Financial Officer (CFO), has been promoted to Chief Operating Officer (COO) and that Michael McDonnell is expected to join Quintiles in ...
read more
Wednesday, October 21, 2015
Catalent Pharma Solutions has announced that Wetteny Joseph has been appointed as its new President, Clinical Supply Services.
read more
Wednesday, October 21, 2015
Downing Labs is voluntarily recalling all lots of sterile products compounded and packaged by Downing Labs and that remain within expiry due to concerns over sterility assurance
read more
Imprimis Pharmaceuticals has made available a customizable compounded formulation of pyrimethamine and leucovorin available for physicians to consider prescribing for their patients as a low cost alternative to Daraprim®.
read more
Perrigo is taking actions to drive substantial profit growth in 2016 and beyond. In total, the actions are expected to add incremental benefits of $175 million when the full run rate of the plan is achieved.
read more
WuXi PharmaTech has announced that its Laboratory Testing Division (LTD) has launched preclinical medical device testing services in China. These services are being offered for Chinese and international clients for their product registration with the...
read more
Quintiles and IMS Health have announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research.
read more
IGI Laboratories, a New Jersey-based specialty generic pharmaceutical company, announced that it will adopt Teligent, Inc. as its new name and will begin trading under a new symbol – TLGT – after ringing the NASDAQ Opening Bell on October 26, 2015.
read more
Recipharm has announced the appointment of a new business director for the Italian pharmaceutical market and a new General Manager at Pessac, France.
read more
Thursday, October 29, 2015
Catalent Pharma Solutions has announced that it is to quadruple cold chain capacity at its existing clinical supply storage and distribution facility in Shanghai, China.
read more
Thursday, October 29, 2015
Bio Products Laboratory, Ltd. (BPL), a manufacturer of plasma-derived therapies, has announced that the U.S. Food and Drug Administration (FDA) has approved Coagadex for the treatment of adults and children (aged 12 years and over) with hereditary ...
read more